Bipolar Schizophrenia

Featured Article

An expert panel that advises the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend a new drug for bipolar I disorder and schizophrenia. The drug, Saphris, was found to safe and effective for the acute treatment of manic or mixed episodes associated with bipolar I disorder, as well as for the acute treatment of schizophrenia in adults. If eventually approved by the FDA, Saphris would be the first drug approved for both indications.

Read more

More information on "Bipolar Schizophrenia"

From Our Experts

See more SharePosts »

From Our Sources

More on Bipolar »